Montreal, Toronto, Vancouver (July 4, 2023) – The adMare Academy invites executives working in life sciences companies across Canada to apply to be part of Cohort VI of the Executive Institute.
Read More
Ottawa, May 31, 2023 – The Health Research Foundation (HRF) of Innovative Medicines Canada is pleased to announce that nominations are now open for the 2023 Diversity and Equity in Research Award. This new award recognizes a remarkable individual whose research demonstrates the highest quality of excellence and advances equitable participation in health research and access to health care in Canada, improving the well-being of all Canadians, particularly those facing inequities.
Read More
MONTRÉAL, June 7, 2023 – Developing new generations of immunotherapies to treat currently incurable pediatric leukemia is the mission of Neomabs Biotechnologies, a new Montreal-based biotechnology company specializing in the discovery and development of innovative oncology therapies.
Read More
Montreal, Toronto, Vancouver (June 6, 2023) – adMare BioInnovations, a leader in the Canadian life sciences sector, is pleased to announce the launch of the adMare Institute, a new voice aimed at advancing the life sciences and related public policy in Canada. The announcement was made today at the prestigious BIO International Conference in Boston.
Read More
MONTREAL, June 5, 2023 /PRNewswire/ - Paraza Pharma is pleased to announce the appointment of Edward W. (Ted) Marple, A.B. (Harvard), MBA (Virginia) as Executive Vice-President, Development.
Read More
The need for easier access to funding for SMBs was an increasingly popular topic in both politics and finance recently.
Read More